Revised February 2013
Office of Extramural Affairs Grant and Contract Review Committees
Code | Committee Name or Description | Scientific Review Officer | Research Areas |
---|---|---|---|
NIDA/K | Training and Career Development |
Eliane Lazar-Wesley, Ph.D. 301-451-4530 |
NIDA's remaining Institute-based standing review committee that reviews grant applications for career development and institutional training in research relevant to NIDA; will transition to CSR October, 2012. |
ZDA1-___- |
Special Emphasis Panels (SEP) |
Various NIDA SROs | A NIDA Special Emphasis Panel (SEP) is recruited by the SRO for a special review, often a unique RFA or a Program Announcement (PA), or for contract proposals. Some recurring SEP reviewed at NIDA are listed below. |
ZDA1-EXL-T | Special Emphasis Panel (SEP) for NIDA Centers |
Eliane Lazar-Wesley, Ph.D. 301-451-4530 |
Review complex multidisciplinary, multi-component applications with administrative and scientific cores and projects related to an integrating theme. |
ZDA1-___- | Special Emphasis Panel (SEP) for assorted FOAs | Various NIDA SROs | Review applications involving multi-site clinical trials, time-sensitive applications, R25 mechanisms, Avant Garde. |
ZDA1-SXC-A |
Special Emphasis Panel(SEP) for Avant-Garde RFA-DA-12-010 |
Scott Chen, Ph.D. 301-443-9511 |
Review grant applications designed by individual scientists of exceptional creativity who propose approaches at the forefront of drug abuse and HIV/AIDS research. |
ZDA1-MXL-A |
Special Emphasis Panel (SEP) for Conference Grants PA-08-149 |
Minna Liang, Ph.D. 301-435-1432 |
Review grant applications for high quality conferences/ scientific meetings relevant to NIDA's scientific and public health issues. |
ZDA1-GXM-A |
Special Emphasis Panel (SEP) for I/START PAR-06-311 |
Gerald McLaughlin, Ph.D. 301-402-6626 |
Review grant applications to facilitate the entry of beginning investigators with brain imaging research relevant to drug abuse. |
ZDA1-SXC-A |
Special Emphasis Panel (SEP) for CEBRA PAR-06-209 |
Scott Chen, Ph.D. 301-443-9511 |
Review grant applications to foster highly innovative or conceptually creative research related to drug abuse and addiction and how to prevent and treat them, and to support high-risk, potentially high-impact that is underrepresented or not included in NIDA's current portfolio. |
*The standing review committees that reviewed the R mechanism, [NIDA/E (Treatment), NIDA/F (Health Services), and NIDA/L (Medication Development)], were dissolved in 2009, and most applications that would have been reviewed in these committees are now being reviewed in CSR.
Click here for rosters of review groups that are managed by the Center for Scientific Review or other Institutes.
General committee information contact:
Ms. Camilla L. Holland,
NIDA Committee Management Officer
(301)435-1384.
For specific committee information contact the Scientific Review Officer listed above.
Office Address:
Office of Extramural Affairs
National Institute on Drug Abuse
National Institutes of Health
6001 Executive Boulevard
Room 4230, MSC 9550
Bethesda, Maryland 20892-9550
Featured Publication
Drugs, Brains, and Behavior - The Science of Addiction
As a result of scientific research, we know that addiction is a disease that affects both brain and behavior.